X-LINKED RETINITIS PIGMENTOSA
Clinical trials for X-LINKED RETINITIS PIGMENTOSA explained in plain language.
Never miss a new study
Get alerted when new X-LINKED RETINITIS PIGMENTOSA trials appear
Sign up with your email to follow new studies for X-LINKED RETINITIS PIGMENTOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Second eye gets gene therapy in bid to halt blindness
Disease control OngoingThis study is testing the safety of a gene therapy injection for the second eye in people with X-linked retinitis pigmentosa, an inherited condition that causes vision loss. It is a follow-up for 24 adults and children who previously received the same treatment in their first eye…
Matched conditions: X-LINKED RETINITIS PIGMENTOSA
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Gene therapy trial seeks to halt vision loss from inherited eye disease
Disease control OngoingThis is a long-term follow-up study for people who received an experimental gene therapy for X-linked retinitis pigmentosa (XLRP), a genetic disease that causes progressive vision loss. The main goals are to check the long-term safety of the treatment and to see if it continues t…
Matched conditions: X-LINKED RETINITIS PIGMENTOSA
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC